INSTITUT CURIE;UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
发明人:
TAZI, JAMAL,GRIERSON, DAVID,MAHUTEAU-BETZER, FLORENCE,ROUX, PIERRE
申请号：
CA2711652
公开号：
CA2711652C
申请日:
2009.01.12
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention relates to a compound of one of the formulas I to XXI； apharmaceutical composition com-prisingat least one such compound； and the use of at least one such compound inpreparing a drug to treat, in a subject, a geneticdisease resulting from at least one splicing anomaly.
